TESEVATINIB MONOTHERAPY EFFICACY AGAINST GBM12 IS ROBUST IN VITRO BUT RELATIVELY MODEST IN THE INTRACRANIAL GBM12 MODEL, DESPITE EXCELLENT BRAIN PENETRATIONSani Kizilbash,Karen Parrish,Janice Laramy,Minjee Kim,Gautham Gampa,Brett Carlson,Katrina Bakken,Mark Schroeder,Paul Decker, James Tonra,William Elmquist,Jann SarkariaNeuro-oncology(2016)引用 0|浏览12暂无评分AI 理解论文溯源树样例生成溯源树,研究论文发展脉络Chat Paper正在生成论文摘要